Sources and Releases
Data Sources
Name | Data types | Version | Last update |
---|---|---|---|
cancer.gov | Drug Indications | Nov 20, 2024 | |
clinicaltrials.gov | Clinical Trials | Nov 20, 2024 | |
PDB | 3D Crystal Structures | Nov 13, 2024 | |
GTEx | Expression | - | Sep 6, 2024 |
TARGET | Mutations, Expression | - | Sep 6, 2024 |
TCGA | Mutations, Expression | - | Sep 6, 2024 |
InnateDB | Interactions | - | Aug 7, 2024 |
UniProt | Proteins | 2024_04 | Jul 24, 2024 |
ChEMBL | Compounds, Bioactivity Data | ChEMBL 34 | Mar 28, 2024 |
intact | Interactions | - | Feb 16, 2024 |
canSAR.ai 3D structure data timeline
Data Counts
Type | # |
---|---|
3D Structures |
220,928 structures, 706,472 chains
|
Cancer studies |
TCGA: 33
TARGET:7
GTEx:54
|
Cell Lines |
35,672
|
Chemical Bioactivities |
13,299,072 datapoints from 79,811 studies
|
Clinical Trials |
516,410
|
Compounds |
4,540,982 unique structures
|
Copy Number Alterations |
DepMap: 34,530,423
ICGC/TCGA: 107,050,671
|
Gene Expression |
TCGA: 640,986,905
DepMap: 23,118,260
|
Interactions by host |
1,012,052 (human)
|
Interactions by type |
Signalling pathways: 11
Enzymatic reactions: 24,007
Direct binding: 25,398
In same complex: 235,299
Transcriptional: 11,865
Drug Synergies: 12,118
Low confidence complex: 715,472
|